FOXO4-DRI is a synthetic peptide that targets and removes senescent (aged) cells, promoting cellular rejuvenation and healthy aging.
Overview
FOXO4-DRI is a specially designed peptide based on the FOXO4 transcription factor, known for its role in cell survival and aging. It works by selectively disrupting the interaction between FOXO4 and p53, a key protein that helps maintain the survival of damaged or senescent cells.
By breaking this interaction, FOXO4-DRI encourages senescent cells to undergo apoptosis (programmed cell death), allowing the body to clear out dysfunctional cells. This process may support tissue regeneration, reduce age-related inflammation, and promote healthier aging.
Research
In animal studies, FOXO4-DRI has shown remarkable effects in reversing signs of aging, improving kidney function, and restoring physical performance. Mice treated with this peptide displayed healthier fur, improved stamina, and increased organ function.
Though still in early phases of clinical research, FOXO4-DRI is being closely studied for its potential in anti-aging therapies, cancer treatments, and age-related diseases. Researchers are exploring safe dosage levels, delivery methods, and long-term impacts of clearing senescent cells in humans.
Reviews
There are no reviews yet.